Devil's Deal?

While personalized medicine may be able to tailor treatments to patients' specific maladies, Eleonore Pauwels and Jim Dratwa from the Woodrow Wilson International Center wonder whether it is a sort of Faustian bargain. Many of the people who contribute their DNA toward the development of personalized medicine may not be able to reap its benefits, they write at the Scientific American Guest Blog.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

NPR reports that Turkish high school students will no longer study evolution.

Researchers report they sequenced and identified plant species in an "al fresco" laboratory.

An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.

In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.